Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Hottinger, A F, Ben Aissa, A, Espeli, V, Squiban, D, Dunkel, N, Vargas, M I, Hundsberger, T, Mach, N, Schaller, K, Weber, D C, Bodmer, A, Dietrich, P-Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877431/
https://www.ncbi.nlm.nih.gov/pubmed/29315292
http://dx.doi.org/10.1038/bjc.2017.469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877431/
https://www.ncbi.nlm.nih.gov/pubmed/29315292
http://dx.doi.org/10.1038/bjc.2017.469

Ejemplares similares